Articles

Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 329 results

Gilenya injunction bid: big pharma takeaways

21-06-2022Azadeh Vahdat

The England and Wales Patent Court affirmed its power to grant injunctions for pre-grant patents—but not for Novartis, explains Azadeh Vahdat of EIP.

Solving the PCT Priority problem

International14-04-2022Chiara Banas

The ‘joint applicants’ approach to PCT applications would provide an elegant solution to issues of who is entitled to priority claims in PCT applications, suggests Chiara Banas of EIP.

When alliances fail, is arbitration the answer?

24-02-2022

The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy

Why mentorship matters

International25-01-2022Muireann Bolger

Effective support and guidance can achieve greater diversity in life sciences, say general counsel from Bristol Myers Squibb, AstraZeneca, The Chemours Company and Eli Lilly.

A guide for life sciences entrepreneurs

International22-12-2021Chad Shear

Small companies face the same long product cycles and upfront costs as the big players but have different IP challenges, explains Chad Shear of Fish & Richardson.

UK experimental use exemptions: part 1—the original

15-07-2021Sophie Topham

In the first of a four-part series, Sophie Topham of Marks & Clerk explores how experimental use provides life sciences products with essential relief from patent infringement

Got a patent, now where to validate?

EU22-03-2021Sarah Kostiuk-Smith

For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.

Patent filing strategies for pharma startups

International16-03-2021Jian Siang Poh and Angus Fairbairn

Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.

The importance of Minerva Surgical v Hologic

US02-02-2021Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks

A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.

What 2020 means for the life sciences

International, UK15-12-2020Sally Shorthose and Rumana Khanom

Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.

Showing 1 to 10 of 329 results

LSIPR